who? An early registration in Canada would generate revenues from commercial sales to offset the cost of additional clinical trial work that may be required. The Company is also seeking new partners in selected jurisdictions. "The Company has identified potential new partners who are interested in obtaining rights to Urocidin™ in certain jurisdictions.
new partners, selected jurisdictions...........I hope they dont hang this carrot in front of our noses forever like they've done with everything else in the past. Dont get me wrong, this is pretty good news. but like those red neck comedians like to say, lets "git'er done"